TreeHouse Foods, Inc. Reports First Quarter 2025 Results
First Quarter Adjusted EBITDA Exceeds Upper-End of
Reiterates 2025 Outlook
- Net sales were
$792.0 million , and adjusted net sales1 were$796.0 million . - Net loss was
$(31.8) million . - Adjusted EBITDA1 of
$57.5 million . - Reaffirmed 2025 outlook of adjusted net sales of
$3.34 to$3.40 billion , adjusted EBITDA of$345 to$375 million , and free cash flow2 of at least$130 million .
"I am grateful to the entire TreeHouse team for its execution this quarter, which resulted in Adjusted EBITDA that exceeded the upper-end of our guidance range," said
FIRST QUARTER 2025 FINANCIAL RESULTS
Net Sales — Net sales for the first quarter of 2025 totaled
|
|
|
Three Months |
|
|
|
(unaudited) |
|
Margin management |
|
(3.3) % |
|
Consumption/other |
|
(2.6) |
|
Griddle recall service impacts |
|
(2.4) |
|
Volume/mix |
|
(8.3) % |
|
Business acquisition |
|
4.7 |
|
Pricing |
|
1.1 |
|
Business exit |
|
(0.4) |
|
Product recall returns |
|
(0.3) |
|
Foreign currency |
|
(0.3) |
|
Total change in net sales |
|
(3.5) % |
|
Product recall returns |
|
0.3 |
|
Total change in adjusted net sales(1) |
|
(3.2) % |
The net sales decrease of 3.5% was primarily due to unfavorable volume/mix related to planned margin management actions, broader macroeconomic consumption trends, and service impacts related to the voluntary recall of frozen griddle products. Additionally, the RTD business exit contributed to the decrease. This was partially offset by the acquisition of the private brand tea business, favorable pricing to recover commodity inflation, and distribution gains.
Gross Profit — Gross profit as a percentage of net sales was 14.5% in the first quarter of 2025, compared to 13.6% in the first quarter of 2024, an increase of 0.9 percentage points. The increase in Gross profit is primarily due to the execution of supply chain savings initiatives, favorable pricing to recover commodity inflation, and a mix benefit from Harris Tea.
Total Operating Expenses — Total operating expenses were
Total Other Expense — Total other expense was
Income Taxes — Income taxes were recognized at an effective rate of 27.1% in the first quarter of 2025 compared to 23.5% recognized in the first quarter of 2024. The change in the Company's effective tax rate is primarily driven by changes in the amounts of executive compensation that is not deductible for tax purposes and the estimated amount of annual pre-tax earnings.
Net Loss and Adjusted EBITDA — Net loss for the first quarter of 2025 was
OUTLOOK2
- Adjusted net sales in a range of
$3.340 billion to$3.400 billion , which represents a decline of approximately 1% to growth of approximately 1% year-over-year driven by:- Volume/mix, which are expected to decline approximately 1% year-over-year due to:
- Organic volume/mix decline approximately 1%
- Harris Tea volume benefit offset by previously announced decision to exit the Ready-to-drink ("RTD") business and other margin management actions, along with one-time impact of frozen griddle product recall.
- Pricing, which is expected to provide an approximately 1% benefit.
- Volume/mix, which are expected to decline approximately 1% year-over-year due to:
- Adjusted EBITDA is expected in a range of
$345 million to$375 million . - Net interest expense is continued to be expected in the range of
$80 to$90 million . - The Company expects capital expenditures of approximately
$125 million . - The Company expects free cash flow of at least
$130 million .
With regard to the second quarter,
- Second quarter adjusted net sales are expected in a range of
$785 to$800 million , which represents approximately flat growth year-over-year at the mid-point. Organic volume and mix are expected to decline mid-single digits, driven primarily by continued margin management actions and the griddle product recall. Pricing is expected to provide an approximately 1% benefit. - Second quarter adjusted EBITDA is expected in a range of
$61 to$71 million , which reflects the shift of$6 million of spend into Q2 from Q1.
________________________________________________
|
1 Adjusted EBITDA, adjusted net sales, and free cash flow are non-GAAP financial measures. See "Comparison of Non-GAAP Information to GAAP Information" for the definitions of the Non-GAAP measures, information concerning certain items affecting comparability, and reconciliations of GAAP to Non-GAAP measures. |
|
|
|
2 The Company is not able to reconcile prospective adjusted net sales, adjusted EBITDA or free cash flow, which are Non-GAAP financial measures, to the most comparable GAAP financial measures without unreasonable effort due to the inherent uncertainty and difficulty of predicting the occurrence, financial impact, and timing of certain items impacting GAAP results. These items include, but are not limited to, mark-to-market adjustments of derivative contracts, foreign currency exchange on the re-measurement of intercompany notes, or other non-recurring events or transactions that may significantly affect reported GAAP results. |
CONFERENCE CALL WEBCAST
A webcast to discuss the Company's first quarter earnings will be held at
COMPARISON OF NON-GAAP INFORMATION TO GAAP INFORMATION
The Company has included in this release measures of financial performance that are not defined by GAAP ("Non-GAAP"). A Non-GAAP financial measure is a numerical measure of financial performance that excludes or includes amounts so as to be different than the most directly comparable measure calculated and presented in accordance with GAAP in the Company's Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Operations, Condensed Consolidated Statements of Comprehensive Loss, Condensed Consolidated Statements of Stockholders' Equity, and the Condensed Consolidated Statements of Cash Flows. As described further below, the Company believes these measures provide useful information to the users of the financial statements.
For each of these Non-GAAP financial measures, the Company provides a reconciliation between the most directly comparable GAAP measure and the Non-GAAP measure, an explanation of why management believes the Non-GAAP measure provides useful information to financial statement users, and any additional purposes for which management uses the Non-GAAP measure. This Non-GAAP financial information is provided as additional information for the financial statement users and is not in accordance with, or an alternative to, GAAP. These Non-GAAP measures may be different from similar measures used by other companies.
EBITDA, EBITDA Margin, Adjusted EBITDA, and Adjusted EBITDA Margin, Adjusting for Certain Items Affecting Comparability
EBITDA margin is defined as EBITDA as a percentage of net sales. Adjusted EBITDA margin is defined as adjusted EBITDA as a percentage of adjusted net sales. EBITDA represents net loss before interest expense, interest income, income tax benefit, and depreciation and amortization expense. Adjusted EBITDA reflects adjustments to EBITDA to identify items that, in management's judgment, significantly affect the assessment of earnings results between periods. This information is provided in order to allow investors to make meaningful comparisons of the Company's earnings performance between periods and to view the Company's business from the same perspective as Company management. As the Company cannot predict the timing and amount of charges that include, but are not limited to, items such as product recalls and related costs, restructuring programs, acquisition, integration, divestiture, and related costs, loss on extinguishment of debt, foreign currency exchange impact on the re-measurement of intercompany notes, mark-to-market adjustments on derivative contracts, and other items that may arise from time to time that would impact comparability, management does not consider these costs when evaluating the Company's performance, when making decisions regarding the allocation of resources, in determining incentive compensation, or in determining earnings estimates. EBITDA and adjusted EBITDA are performance measures commonly used by management to assess operating performance and incentive compensation, and the Company believes they are commonly reported and widely used by investors and other interested parties as a measure of a company's operating performance between periods and as a component of our debt covenant calculations.
Adjusted
Adjusted net sales, adjusted cost of sales, adjusted gross profit, adjusted total operating expenses, adjusted operating income, adjusted total other expense, adjusted income tax expense (benefit), and adjusted net income (loss) represent their respective GAAP presentation line item adjusted for items such as product recalls and related costs, restructuring programs, acquisition, integration, divestiture, and related costs, loss on extinguishment of debt, foreign currency exchange impact on the re-measurement of intercompany notes, mark-to-market adjustments on derivative contracts, and other items that may arise from time to time that would impact comparability. Management does not consider these costs when evaluating the Company's performance, when making decisions regarding the allocation of resources, in determining incentive compensation, or in determining earnings estimates. This information is provided in order to allow investors to make meaningful comparisons of the Company's earnings performance between periods and to view the Company's business from the same perspective as Company management. The Company has presented each of these adjusted Non-GAAP measures as a percentage of adjusted net sales compared to its respective reported GAAP presentation line item as a percentage of net sales. Adjusted diluted earnings (loss) per share ("Adjusted diluted EPS") is determined by dividing adjusted net income (loss) by the weighted average diluted common shares outstanding. Adjusted diluted EPS reflects adjustments to GAAP earnings (loss) per diluted share to identify items that, in management's judgment, significantly affect the assessment of earnings results between periods.
Given the inherent uncertainty regarding adjusted items in any future period, a reconciliation of forward-looking financial measures to the most directly comparable GAAP measure is not feasible.
Free Cash Flow
In addition to measuring our cash flow generation and usage based upon the operating, investing, and financing classifications included in the Condensed Consolidated Statements of Cash Flows, we also measure free cash flow (a Non-GAAP measure) which represents net cash used in operating activities, less capital expenditures and proceeds from sales of fixed assets. We believes free cash flow is an important measure of liquidity because it provides management and investors a measure of cash generated from operations that is available for mandatory payment obligations and investment opportunities such as funding acquisitions, repaying debt, repurchasing public debt, and repurchasing common stock. A reconciliation between the relevant GAAP measure of cash used in operating activities for the three months ended
ABOUT
Additional information, including TreeHouse's most recent statements on Forms 10-Q and 10-K, may be found at TreeHouse's website, http://www.treehousefoods.com.
FORWARD-LOOKING STATEMENTS
This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements and other information are based on our beliefs, as well as assumptions made by us, using information currently available. The words "believe," "estimate," "project," "expect," "anticipate," "plan," "intend," "foresee," "should," "would," "could," and similar expressions, as they relate to us, are intended to identify forward-looking statements. Such statements reflect our current views with respect to future events and are subject to certain risks, uncertainties, and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, or intended. We do not intend to update these forward-looking statements following the date of this press release. Such forward-looking statements, because they relate to future events, are by their very nature subject to many important factors that could cause actual results to differ materially from those contemplated by the forward-looking statements contained in this press release and other public statements we make. Such factors include, but are not limited to: risks related to quality issues, disruptions, or inefficiencies in our supply chain and/or operations; product recalls; loss or consolidation of key suppliers; raw material and commodity costs due to inflation; labor strikes or work stoppages; multiemployer pension plans; labor shortages and increased competition for labor; success of our restructuring programs; our level of indebtedness and related obligations; disruptions in the financial markets; uncertain effects, both direct and indirect, of changes and volatility in tariffs and trade policies; interest rates; changes in foreign currency exchange rates; customer concentration and consolidation; competition; our ability to execute on our business strategy; our ability to continue to make acquisitions and execute on divestitures or effectively manage the growth from acquisitions; impairment of goodwill or long lived assets; changes and developments affecting our industry, including customer preferences and the prevalence of weight loss drugs; the outcome of litigation and regulatory proceedings to which we and/or our customers may be a party; changes in laws and regulations applicable to us; shareholder activism; disruptions in or failures of our information technology systems; geopolitical events; changes in weather conditions, climate changes, and natural disasters; and other risks that are set forth in the Risk Factors section, the Legal Proceedings section, the Management's Discussion and Analysis of Financial Condition and Results of Operations section, and other sections of our Annual Report on Form 10-K for the year ended
FINANCIAL INFORMATION
|
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited, in millions, except per share data) |
||||
|
|
||||
|
|
|
|
|
|
|
Assets |
|
|
|
|
|
Current assets: |
|
|
|
|
|
Cash and cash equivalents |
|
$ 16.4 |
|
$ 289.6 |
|
Receivables, net |
|
132.7 |
|
146.8 |
|
Inventories |
|
589.2 |
|
539.3 |
|
Prepaid expenses and other current assets |
|
37.2 |
|
34.0 |
|
Total current assets |
|
775.5 |
|
1,009.7 |
|
Property, plant, and equipment, net |
|
757.5 |
|
748.6 |
|
Operating lease right-of-use assets |
|
190.9 |
|
154.4 |
|
|
|
1,889.1 |
|
1,819.3 |
|
Intangible assets, net |
|
278.7 |
|
212.9 |
|
Other assets, net |
|
35.6 |
|
35.1 |
|
Total assets |
|
$ 3,927.3 |
|
$ 3,980.0 |
|
Liabilities and Stockholders' Equity |
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
Accounts payable |
|
$ 509.4 |
|
$ 602.5 |
|
Accrued expenses |
|
165.9 |
|
141.3 |
|
Current portion of long-term debt |
|
5.4 |
|
1.1 |
|
Total current liabilities |
|
680.7 |
|
744.9 |
|
Long-term debt |
|
1,417.4 |
|
1,401.3 |
|
Operating lease liabilities |
|
153.8 |
|
125.4 |
|
Deferred income taxes |
|
104.6 |
|
105.8 |
|
Other long-term liabilities |
|
51.9 |
|
53.7 |
|
Total liabilities |
|
2,408.4 |
|
2,431.1 |
|
Commitments and contingencies |
|
|
|
|
|
Stockholders' equity: |
|
|
|
|
|
Preferred stock, par value |
|
— |
|
— |
|
Common stock, par value |
|
0.6 |
|
0.6 |
|
|
|
(385.4) |
|
(385.4) |
|
Additional paid-in capital |
|
2,240.0 |
|
2,238.4 |
|
Accumulated deficit |
|
(253.8) |
|
(222.0) |
|
Accumulated other comprehensive loss |
|
(82.5) |
|
(82.7) |
|
Total stockholders' equity |
|
1,518.9 |
|
1,548.9 |
|
Total liabilities and stockholders' equity |
|
$ 3,927.3 |
|
$ 3,980.0 |
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited, in millions, except per share data) |
||||
|
|
||||
|
|
|
Three Months Ended
|
||
|
|
|
2025 |
|
2024 |
|
Net sales |
|
$ 792.0 |
|
$ 820.7 |
|
Cost of sales |
|
676.8 |
|
708.7 |
|
Gross profit |
|
115.2 |
|
112.0 |
|
Operating expenses: |
|
|
|
|
|
Selling and distribution |
|
36.4 |
|
42.9 |
|
General and administrative |
|
55.7 |
|
55.8 |
|
Amortization expense |
|
13.1 |
|
12.1 |
|
Other operating expense, net |
|
15.5 |
|
6.4 |
|
Total operating expenses |
|
120.7 |
|
117.2 |
|
Operating loss |
|
(5.5) |
|
(5.2) |
|
Other expense: |
|
|
|
|
|
Interest expense |
|
19.3 |
|
15.6 |
|
Interest income |
|
(2.8) |
|
(4.0) |
|
Loss on extinguishment of debt |
|
2.6 |
|
— |
|
(Gain) loss on foreign currency exchange |
|
(0.3) |
|
3.4 |
|
Other expense (income), net |
|
19.3 |
|
(4.9) |
|
Total other expense |
|
38.1 |
|
10.1 |
|
Loss before income taxes |
|
(43.6) |
|
(15.3) |
|
Income tax benefit |
|
(11.8) |
|
(3.6) |
|
Net loss |
|
$ (31.8) |
|
$ (11.7) |
|
|
|
|
|
|
|
Earnings (loss) per common share: |
|
|
|
|
|
Basic |
|
$ (0.63) |
|
$ (0.22) |
|
Diluted |
|
(0.63) |
|
(0.22) |
|
Weighted average common shares: |
|
|
|
|
|
Basic |
|
50.3 |
|
53.8 |
|
Diluted |
|
50.3 |
|
53.8 |
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited, in millions) |
||||
|
|
||||
|
|
|
Three Months Ended
|
||
|
|
|
2025 |
|
2024 |
|
Cash flows from operating activities: |
|
|
|
|
|
Net loss |
|
$ (31.8) |
|
$ (11.7) |
|
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
Depreciation and amortization |
|
41.4 |
|
36.6 |
|
Stock-based compensation |
|
5.6 |
|
5.7 |
|
Loss on extinguishment of debt |
|
2.6 |
|
— |
|
Unrealized loss (gain) on derivative contracts |
|
17.0 |
|
(7.0) |
|
Other, net |
|
(0.9) |
|
5.0 |
|
Changes in operating assets and liabilities, net of acquisitions: |
|
|
|
|
|
Receivables |
|
27.5 |
|
2.9 |
|
Inventories |
|
(8.0) |
|
(9.6) |
|
Prepaid expenses and other assets |
|
(14.4) |
|
(8.4) |
|
Accounts payable |
|
(103.2) |
|
(48.2) |
|
Accrued expenses and other liabilities |
|
10.7 |
|
(17.7) |
|
Net cash used in operating activities |
|
(53.5) |
|
(52.4) |
|
Cash flows from investing activities: |
|
|
|
|
|
Capital expenditures |
|
(25.9) |
|
(28.3) |
|
Proceeds from sales of fixed assets |
|
4.1 |
|
0.2 |
|
Acquisition, net of cash acquired |
|
(209.3) |
|
— |
|
Net cash used in investing activities |
|
(231.1) |
|
(28.1) |
|
Cash flows from financing activities: |
|
|
|
|
|
Borrowings under Revolving Credit Facility |
|
697.3 |
|
— |
|
Payments under Revolving Credit Facility |
|
(672.3) |
|
— |
|
Payments on financing lease obligations |
|
(0.3) |
|
(0.1) |
|
Payment of deferred financing costs |
|
(3.7) |
|
— |
|
Payments on Term Loans |
|
(905.0) |
|
— |
|
Proceeds from refinanced Term Loans |
|
899.2 |
|
— |
|
Repurchases of common stock |
|
— |
|
(43.9) |
|
Payments related to stock-based award activities |
|
(4.0) |
|
(3.8) |
|
Net cash provided by (used in) financing activities |
|
11.2 |
|
(47.8) |
|
Effect of exchange rate changes on cash and cash equivalents |
|
0.2 |
|
(0.2) |
|
Net decrease in cash and cash equivalents |
|
(273.2) |
|
(128.5) |
|
Cash and cash equivalents, beginning of period |
|
289.6 |
|
320.3 |
|
Cash and cash equivalents, end of period |
|
$ 16.4 |
|
$ 191.8 |
|
|
|
Three Months Ended
|
||
|
|
|
2025 |
|
2024 |
|
Supplemental cash flow disclosures: |
|
|
|
|
|
Interest paid |
|
$ 27.2 |
|
$ 26.3 |
|
Net income taxes paid |
|
0.9 |
|
0.6 |
|
|
|
|
|
|
|
Non-cash investing and financing activities: |
|
|
|
|
|
Capital expenditures incurred but not yet paid |
|
15.9 |
|
11.7 |
|
Right-of-use assets obtained in exchange for lease obligations |
|
40.9 |
|
(1.7) |
|
Preliminary purchase price adjustment for private brand tea business acquisition |
|
2.0 |
|
— |
|
Accrued deferred financing costs |
|
0.2 |
|
— |
The following table reconciles the Company's net loss to EBITDA and adjusted EBITDA, for the three months ended
|
RECONCILIATION OF NET LOSS TO EBITDA AND ADJUSTED EBITDA (Unaudited, in millions) |
||||
|
|
||||
|
|
|
Three Months Ended |
||
|
|
|
2025 |
|
2024 |
|
Net loss (GAAP) |
|
$ (31.8) |
|
$ (11.7) |
|
Interest expense |
|
19.3 |
|
15.6 |
|
Interest income |
|
(2.8) |
|
(4.0) |
|
Income tax benefit |
|
(11.8) |
|
(3.6) |
|
Depreciation and amortization |
|
41.4 |
|
36.6 |
|
EBITDA (Non-GAAP) |
|
14.3 |
|
32.9 |
|
Mark-to-market adjustments(1) |
|
17.0 |
|
(7.0) |
|
Restructuring programs & other, excluding accelerated depreciation(2) |
|
15.4 |
|
6.7 |
|
Product recalls and related costs(3) |
|
5.9 |
|
6.9 |
|
Loss on extinguishment of debt(4) |
|
2.6 |
|
— |
|
Acquisition, integration, divestiture, and related costs(5) |
|
2.5 |
|
4.1 |
|
Foreign currency (gain) loss on re-measurement of intercompany notes(6) |
|
(0.2) |
|
2.4 |
|
Adjusted EBITDA (Non-GAAP) |
|
$ 57.5 |
|
$ 46.0 |
|
|
|
|
|
|
|
% of net sales |
|
|
|
|
|
Net loss margin |
|
(4.0) % |
|
(1.4) % |
|
EBITDA margin |
|
1.8 % |
|
4.0 % |
|
|
|
|
|
|
|
% of adjusted net sales |
|
|
|
|
|
Adjusted EBITDA margin |
|
7.2 % |
|
5.6 % |
During the three months ended
|
(1) |
The Company's derivative contracts are marked-to-market each period. The non-cash unrealized changes in fair value recognized in Other expense (income), net within the Condensed Consolidated Statements of Operations are treated as Non-GAAP adjustments. As the contracts are settled, realized gains and losses are recognized, and only the mark-to-market impacts are treated as Non-GAAP adjustments. |
|
|
|
|
(2) |
The Company's restructuring and margin improvement activities are part of an enterprise-wide transformation to improve the long-term profitability of the Company. During the first quarter of 2025, the Company recognized |
|
|
|
|
(3) |
Griddle Recall and Related Costs
On
Broth Recall and Related Costs
On |
|
|
|
|
(4) |
During the three months ended |
|
|
|
|
(5) |
Acquisition, integration, divestiture, and related costs represents costs associated with completed and potential acquisitions, the related integration of the acquisitions, completed and potential divestitures, and gains or losses on the divestiture of a business. During the three months ended |
|
|
|
|
(6) |
The Company has foreign currency denominated intercompany loans and incurred foreign currency gains/losses to re-measure the loans at quarter end. These amounts are non-cash and the loans are eliminated in consolidation. |
|
|
|
The following tables reconcile the Company's Adjusted net sales, Adjusted cost of sales, Adjusted gross profit, Adjusted total operating expenses, Adjusted operating income, Adjusted total other expense, Adjusted income tax expense (benefit), and Adjusted net income (loss) to their most directly comparable GAAP measure, for three months ended
|
RECONCILIATION OF NON-GAAP MEASURES (Unaudited, in millions, except per share amounts) |
||||||||||||||||
|
|
||||||||||||||||
|
|
|
Three Months Ended |
||||||||||||||
|
|
|
|
||||||||||||||
|
|
|
Net sales |
|
Cost of |
|
Gross |
|
Total |
|
Operating |
|
Total |
|
Income |
|
Net (loss) |
|
As reported (GAAP) |
|
$ 792.0 |
|
$ 676.8 |
|
$ 115.2 |
|
$ 120.7 |
|
$ (5.5) |
|
$ 38.1 |
|
$ (11.8) |
|
$ (31.8) |
|
Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mark-to-market adjustments(1) |
|
— |
|
— |
|
— |
|
— |
|
— |
|
(17.0) |
|
— |
|
17.0 |
|
Restructuring programs & other, including accelerated |
|
— |
|
(2.8) |
|
2.8 |
|
(15.5) |
|
18.3 |
|
— |
|
— |
|
18.3 |
|
Product recalls and related costs(3) |
|
3.7 |
|
0.1 |
|
3.6 |
|
(2.3) |
|
5.9 |
|
— |
|
— |
|
5.9 |
|
Loss on extinguishment of debt(4) |
|
— |
|
— |
|
— |
|
— |
|
— |
|
(2.6) |
|
— |
|
2.6 |
|
Acquisition, integration, divestiture, and related costs(5) |
|
0.3 |
|
(1.9) |
|
2.2 |
|
(0.3) |
|
2.5 |
|
— |
|
— |
|
2.5 |
|
Foreign currency gain on re-measurement of intercompany notes(6) |
|
— |
|
— |
|
— |
|
— |
|
— |
|
0.2 |
|
— |
|
(0.2) |
|
Taxes on adjusting items |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
12.8 |
|
(12.8) |
|
As adjusted (Non-GAAP) |
|
$ 796.0 |
|
$ 672.2 |
|
$ 123.8 |
|
$ 102.6 |
|
$ 21.2 |
|
$ 18.7 |
|
$ 1.0 |
|
$ 1.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As reported (% of net sales) |
|
|
|
|
|
14.5 % |
|
15.2 % |
|
(0.7) % |
|
4.8 % |
|
(1.5) % |
|
(4.0) % |
|
As adjusted (% of adjusted net sales) |
|
|
|
|
|
15.6 % |
|
12.9 % |
|
2.7 % |
|
2.3 % |
|
0.1 % |
|
0.2 % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ (0.63) |
|
Adjusted diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.03 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted for net loss |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50.3 |
|
Diluted for adjusted net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50.4 |
|
|
|
Three Months Ended |
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
Cost of |
|
Gross |
|
Total |
|
Operating |
|
Total |
|
Income |
|
Net loss |
|
As reported (GAAP) |
|
$ 820.7 |
|
$ 708.7 |
|
$ 112.0 |
|
$ 117.2 |
|
$ (5.2) |
|
$ 10.1 |
|
$ (3.6) |
|
$ (11.7) |
|
Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mark-to-market adjustments(1) |
|
— |
|
— |
|
— |
|
— |
|
— |
|
7.0 |
|
— |
|
(7.0) |
|
Restructuring programs & other(2) |
|
— |
|
— |
|
— |
|
(6.7) |
|
6.7 |
|
— |
|
— |
|
6.7 |
|
Product recalls and related costs(3) |
|
0.9 |
|
(6.0) |
|
6.9 |
|
— |
|
6.9 |
|
— |
|
— |
|
6.9 |
|
Acquisition, integration, divestiture, and related costs(5) |
|
— |
|
(1.9) |
|
1.9 |
|
(2.2) |
|
4.1 |
|
— |
|
— |
|
4.1 |
|
Foreign currency loss on re-measurement of intercompany notes(6) |
|
— |
|
— |
|
— |
|
— |
|
— |
|
(2.4) |
|
— |
|
2.4 |
|
Taxes on adjusting items |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
3.2 |
|
(3.2) |
|
As adjusted (Non-GAAP) |
|
$ 821.6 |
|
$ 700.8 |
|
$ 120.8 |
|
$ 108.3 |
|
$ 12.5 |
|
$ 14.7 |
|
$ (0.4) |
|
$ (1.8) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As reported (% of net sales) |
|
|
|
|
|
13.6 % |
|
14.3 % |
|
(0.6) % |
|
1.2 % |
|
(0.4) % |
|
(1.4) % |
|
As adjusted (% of adjusted net sales) |
|
|
|
|
|
14.7 % |
|
13.2 % |
|
1.5 % |
|
1.8 % |
|
— % |
|
(0.2) % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ (0.22) |
|
Adjusted diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ (0.03) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted for net loss |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
53.8 |
|
Diluted for adjusted net loss |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
53.8 |
|
RECONCILIATION OF (Unaudited, in millions) |
||||
|
|
||||
|
|
|
Three Months Ended
|
||
|
|
|
2025 |
|
2024 |
|
|
|
|
||
|
Cash flow used in operating activities (GAAP) |
|
$ (53.5) |
|
$ (52.4) |
|
Capital expenditures |
|
(25.9) |
|
(28.3) |
|
Proceeds from sales of fixed assets |
|
4.1 |
|
0.2 |
|
Free cash flow (Non-GAAP) |
|
$ (75.3) |
|
$ (80.5) |
View original content:https://www.prnewswire.com/news-releases/treehouse-foods-inc-reports-first-quarter-2025-results-302446453.html
SOURCE
